New diagnostic breakthrough predicts which head and neck cancer patients can be cured with surgery alone
Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor Jukka Westermarck, have identified a novel diagnostic tool that can revolutionize the treatment guidance of head and neck squamous cell carcinoma.
Their newly published study introduces an easy-to-use immunohistochemical assay for detecting the LIMA1-alpha protein, which reliably predicts whether patients can be cured with surgery alone—avoiding the need for harmful oncological treatments.
“Our findings suggest that immunohistochemical detection of LIMA1-alpha can serve as a reliable and cost-effective tool for identifying patients who could be cured with surgery only and thus spared from the burden of multimodal treatments,” says Docent Ventelä. “This kind of stratification is long overdue and needed in head and neck cancer care.”
Recent Posts
-
Christel Sourander Successfully Defends Her Thesis
Christel Sourander successfully defended her thesis: “Identifying the effect of JNK on neural activity and Read moreSeptember 9, 2025
-
Researchers at Åbo Akademi University Discover a New Molecular Switch Regulating Breast Cancer Progression
A research group led by our our affiliated group leader Professor Lea Sistonen at Åbo Read moreSeptember 4, 2025
-
Autumn 2025 Frontiers of Science seminars start soon
Frontiers of Science is a long-running seminar series, celebrating over 25 years of bringing internationally Read moreSeptember 3, 2025
-
The Elias Tillandz Prize to Turku Bioscience Researchers
The Elias Tillandz Prize for the Best Scientific Publication of 2024 was presented for two Read moreSeptember 2, 2025
-
Registration to FFGC Sequencing day is open!
Registration to FFGC Sequencing day is open! The event is organized by Finnish Functional Genomics Read moreAugust 27, 2025
-
Dr. Inna Starskaia received a three-year training award from Breakthrough T1D
Dr. Inna Starskaia has been awarded a prestigious three-year training award from Breakthrough T1D, the Read moreAugust 22, 2025